Fox Chase Cancer Center; Hematology/Oncology

Philadelphia, Pennsylvania 19111

0 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Renal Cell Carcinoma

Studies at this site

• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early
• A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed